LACDR Spring Symposium 2024
InnovationActa
On May 14 2024, Jill represented the Division of BioTherapeutics in the annual LACDR Spring Symposium and presented her research on age-associated B cells in atherosclerosis. The LACDR Spring Symposium is attended by ~150 LACDR employees. In addition, master students of BioPharmaceutical Sciences attend this Symposium to learn about our research and for whom this is a training activity.
Presentation FCVB 12 Aprile 2024
InnovationActa
The ULEI team participated at the European Society of Cardiology: Frontiers in CardioVascular Biomedicine 2024 Congress held in Amsterdam, Netherlands on the 12th– 14th of April 2024.
The ULEI team includes Assoc. Prof. Amanda Foks, Prof. Ilze Bot and the PhD candidate Jill de Mol (photo on the right).
Amanda Foks invited talk was entitled “Age-associated B cell immunity in atherosclerosis”
New PhD students
Welcome to
Kauthar Parker (Kauthar Parker - Leiden University (universiteitleiden.nl))
Anna Witteveen (Anna Witteveen - Leiden University (universiteitleiden.nl))
Jill de Mol (Jill de Mol - Leiden University (universiteitleiden.nl))
European symposium on controlled drug delivery
InnovationActa
B-specific PI, Assoc. Prof. Bram Slütter was invited to the European Symposium of Controlled Drug Delivery, held between 10th to 12th April at Egmond aan Zee, Netherland. His talk was entitled ‘Platforms for Induction of Antigen Specific Tolerance in Cardiovascular Disease’.
"A crown per heartbeat" in Sweden
InnovationActa
On March 14th, Samuel Andersson from the ULUND team spoke at an event called “en krona per hjärtslag” (“a crown per heartbeat”) in Helsingborg, Sweden. The public event organized by high school students from Johannes Hedberggymnasiet, aimed to raise funds for cardiovascular research by collecting as many Swedish crowns as there are heartbeats in 2 hours (duration of the event).
In his talk entitled “Hjärt-kärlsjukdomar och forskning – en kort historia” (“Cardiovascular diseases and research – a short story”), Samuel discussed the history of cardiovascular research and immunology introducing his PhD research, focusing on studying B cells and their role in atherosclerosis.
Samuel emphasized how the activities at ULUND have contributed to cardiovascular research through SCAPIS, FIMCOD, and other studies that have led to compounds being tested in clinical trials. Overall, the event was a great success, surpassing the original fundraising goal by almost three times.
Photo by Rickard Lindblom
B-specific Coordinator was invited to three important scientific events
InnovationActa
B-specific coordinator Assoc. Prof. Amanda Foks was invited to three important scientific events during February and March 2024, in which she presented data on age-associated immunity, particularly ABCs, in atherosclerosis, including pathophysiology and potential targets for therapy.
She gave talks at
Vascular Medicine and Atherosclerosis Congress 2024, Augsburg, Germany on the 23rd of February;
Danish Academy Winter Meeting 2024, Norefjell, Norway on 29th of February;
Dutch German Joint Meeting of the Molecular Cardiology Working Groups, UMC Groningen, Netherlands on the 15th if March.
Talk at the Annual Scandinavian Atherosclerosis Conference
On Thursday, March 14, 2024, Pernilla Katra (ULUND), a PhD-student in the B-specific consortium, delivered a talk entitled ”Age-associated B cells are clonally expanded, aggravate murine plaque development and are associated with coronary events in humans” based on recent findings in the B-specific project at the 30th Annual Scandinavian Atherosclerosis Conference held March 13–16, 2024 at Krogerup Højskole, Humlebæk, Denmark.
Pernilla’s talk was selected from submitted abstracts to be presented orally at the conference. The annual conference has been held since 1994 and is organized by the Scandinavian Society of Atherosclerosis Research founded in 1977 (SSAR, www.ssar.dk). The aim of the society is to promote atherosclerosis research with special emphasis on Scandinavian as well as international collaboration, mainly by organizing the annual international conference on atherosclerosis research.
Theranostic target molecules for adapter CAR-T cell therapies
Dr. Anja Feldman (HZRD) participated at the IGLD 26th yearly symposium held between 7th-9th March 2024 in Leipzig, Germany.
Dr. Feldman's talk was entitled 'Theranostic target molecules for adapter CAR-T cell therapies'.
Radio interview
InnovationActa
On February 24th 2024 Assoc. Prof. Bram Slütter (ULEI) did a radio interview on national newsradio discussing recent advances in the cardiovascular field (NPO1).
Presentation Young PI meeting
InnovationActa
The Young Cardiovascular PI meeting took place on the 24th of January 2024 at Bergeijk, Netherlands. The meeting was attended by B-specific coordinator Assoc. Prof. Amanda Foks (invited) and PhD candidate Jill de Mol. Amanda and Jill presented research on single-cell profiling of age-associated B-cell immunity in atherosclerosis.
